iBankCoin
Joined Feb 3, 2009
1,759 Blog Posts

AIG Looking For a Fourth Potential Balout Giving Grim Warnings if it Fails

AIG is a unstable nuclear bomb

March 9 (Bloomberg) — American International Group Inc. appealed for its fourth U.S. rescue by telling regulators the company’s collapse could cripple money-market funds, force European banks to raise capital, cause competing life insurers to fail and wipe out the taxpayers’ stake in the firm.

AIG needed immediate help from the Federal Reserve and Treasury to prevent a “catastrophic” collapse that would be worse for markets than the demise last year of Lehman Brothers Holdings Inc., according to a 21-page draft AIG presentation dated Feb. 26, labeled as “strictly confidential” and circulated among federal and state regulators.

“What happens to AIG has the potential to trigger a cascading set of further failures which cannot be stopped except by extraordinary means,’’ said the presentation by New York- based AIG. “Insurance is the oxygen of the free enterprise system. Without the promise of protection against life’s adversities, the fundamentals of capitalism are undermined.’’

Regulators revised AIG’s bailout last week to ease loan terms and extend $30 billion in fresh capital after the firm posted a $61.7 billion fourth-quarter loss, the worst in U.S. corporate history. Lawmakers are reluctant to give more support beyond the package already in place, worth about $160 billion, because they say regulators haven’t given enough detail about how the funds are being used or when the bailouts will end.

The Fed is “asking for an open-ended check’’ and is “not going to get” it, Senator Robert Menendez, a New Jersey Democrat, said last week in Congressional hearings.

Global Impact

AIG warned of turmoil around the globe if the government allowed the insurer to fail, adding “it is questionable whether the economy could tolerate another shock to the system that a failure of AIG would produce.” The value of the U.S. dollar might fall, Treasury borrowing costs could rise and the agency would face “doubts about the ability of the U.S. to support its banking system,” according to the presentation, parts of which were reported earlier by the New York Times.

Under the scenarios sketched by AIG, European banks that bought credit-default swaps might need to raise $10 billion in capital and could face rating downgrades. Life insurance customers, their faith shaken in the industry, would redeem some of their $19 trillion in U.S. policies, overwhelming firms already weakened by the credit crisis, AIG said.

The $38 billion in support provided by the firm to money- market funds would be in jeopardy, AIG said, possibly forcing some to “break the buck.’’ The term refers to a money fund that suffers losses so large that it must pay investors less than the traditional $1-a-share value that gives the short-term funds their reputation for safety.

Overseas Seizures

Outside the U.S., where AIG operates in more than 140 countries, a collapse could lead to the “immediate seizure’’ of its businesses by regulators and could impair “the entire insurance industry within certain regions,’’ the presentation said, which added that its conclusions were “speculative’’ and a matter of judgment.

“Who knows if what they’re saying is true?’’ said Phillip Phan, professor of management at the Johns Hopkins Carey Business School in Baltimore. “A lot of it sounds like conjecture, that if AIG collapses the rest of the industry will, too. It’s a way of creating a crisis atmosphere and the sense you have to respond quickly.’’

AIG’s latest rescue package includes equity, new credit and lower interest rates on existing loans designed to keep it in business. Federal Reserve Chairman Ben S. Bernanke and Treasury Secretary Timothy Geithner have said the government must prop up AIG to avoid damaging the financial system.

Fed spokeswoman Michelle Smith said the central bank “came to its conclusions based on our own analysis.” Christina Pretto, an AIG spokeswoman and Isaac Baker of the Treasury didn’t immediately have a comment.

Bailout Beneficiaries

New York Insurance Superintendent Eric Dinallo said at a March 5 hearing he’d received the presentation.

The document doesn’t say which other companies have benefited from AIG’s repeated rescues. Goldman Sachs Group Inc. and Deutsche Bank AG were among at least two dozen financial institutions that were paid $50 billion from the bailout funds received by AIG, the Wall Street Journal reported, citing a confidential document and people familiar with the matter whom it didn’t identify.

Goldman and Deutsche got about $6 billion each between September and December, the Journal said. Merrill Lynch & Co., Societe Generale SA, Morgan Stanley, Royal Bank of Scotland Group Plc and HSBC Holdings Plc were other counterparties that also received payments, the newspaper said, citing the document.

Taxpayer Wipeout

AIG’s presentation said that without more U.S. help, investment losses would mean “AIG will not be able to repay its obligations” and that cash previously provided by the U.S., which controls a 79.9 percent stake in the insurer, could be lost. Chief Executive Officer Edward Liddy, who took over the top job in September, has vowed that AIG will repay all of its debts to taxpayers.

At AIG itself, failure could have led to dismissals from its workforce of 116,000, the document said. At that level, the staff is unchanged from the end of 2007 before AIG’s bailout. The global credit crunch has led to at least 284,000 job cuts at the rest of the world’s financial companies, according to Bloomberg data.

The insurer’s first bailout package, crafted last September, later grew to $150 billion. After failing to sell enough subsidiaries to repay the government, AIG had to turn to U.S. taxpayers again. The company may need more support if financial markets don’t improve, the Treasury and Federal Reserve said last week in a joint statement.

Comments »

MRK To Buy SGP for $41 Billion

Mega merger

March 9 (Bloomberg) — Merck & Co. agreed to buy rival U.S. drugmaker Schering-Plough Corp. for $41.1 billion in cash and stock to get a larger experimental pipeline and products unhindered by imminent patent losses.

Schering-Plough holders will get $23.61 a share, a 34 percent premium to the closing stock price last week, the companies said in a Business Wire statement. Shares of Kenilworth, New Jersey-based Schering-Plough rose the most in a month in New York trading on March 6 on speculation of a bid from Merck or Johnson & Johnson.

“It clearly is a year of mergers for pharmaceutical companies,” said Philippe Lanone, an analyst at Natixis Securities in Paris, in a telephone interview. “They don’t have much of a choice if they are to guarantee EPS growth in the years to come.”

Schering-Plough has medicines in late-stage testing that may generate more than $6 billion in annual sales, the company said at a November analyst meeting. Last month, Schering-Plough’s earnings beat analyst estimates after the drugmaker added sales from its acquisition of Organon BioSciences and reduced costs.

Under the terms of the deal, Schering-Plough shareholders will receive 0.5767 shares and $10.50 in cash for each share of Schering-Plough. The cash portion will be financed with a combination of $9.8 billion from existing cash balances and $8.5 billion from committed financing to be provided by JPMorgan Chase & Co.

Stock Premium

The price also represents a premium of about 44 percent based on the average closing price of the two stocks over the last 30 trading days.

Upon closing, Merck shareholders are expected to own about 68 percent of the combined company, and Schering-Plough shareholders are expected to own approximately 32 percent. Merck anticipates that the transaction will “modestly” add to non- GAAP earnings in the first full year following completion and “significantly” thereafter.

Merck Chief Executive Officer Richard T. Clark will lead the combined company. Merck said it’s committed to maintaining the dividend at its current level.

Schering-Plough rose $1.31, or 8 percent, to close at $17.63 March 6 in composite New York Stock Exchange trading, its biggest jump since Feb. 3 when it announced quarterly earnings above analyst estimates. Schering-Plough’s shares climbed 2.1 percent higher in extended trading.

Merck rose 60 cents, or 2.7 percent, to $22.74. Schering- Plough co-markets its top-selling anti-inflammatory drug Remicade with J&J, and developed the cholesterol pills Vytorin and Zetia with Merck.

In Development

Schering-Plough’s most promising treatment in development, called TRA, is designed to prevent blood clots with fewer side effects than older drugs and could come on the market as early as 2011.

Schering-Plough shares the revenue of its Zetia and Vytorin cholesterol pills, which generated $5 billion last year, with Merck.

As of Jan. 31, U.S. sales of Vytorin had slid 43 percent and Zetia 33 percent since a January 2008 study questioned whether the drugs were better at unclogging arteries than an older, cheaper pill. Schering-Plough Chief Executive Officer Fred Hassan has been firing workers and closing factories to save $1.25 billion by 2010 to recoup some of the cholesterol pill losses.

Concerns over the falling cholesterol pill sales sent Schering’s stock price down 36 percent in 2008.

Pharmacia Corp.

Hassan, who took the helm at Schering-Plough in 2003, rebuilt crippled Pharmacia Corp. and sold it to Pfizer Inc. for $58 billion, engineered the $37 billion takeover of Monsanto Co., and made Schering-Plough profitable after losses in 2003 and 2004. Hassan, 63, was born in Pakistan and began his career in 1970 as a drug salesman. Schering’s Remicade deal with Johnson & Johnson allows it to sell the medicine outside the U.S., Japan and parts of Asia.

Remicade, a treatment for rheumatoid arthritis, generated $2.19 billion for Schering-Plough last year, 16 percent of company revenue. It was also Johnson & Johnson’s top selling drug, with $3.75 billion in sales. The two companies share rights to golimumab, an experimental successor to Remicade, and their agreements give J&J sole rights to Remicade if Schering is sold, said Linda Bannister, an Edward Jones & Co. analyst in St. Louis, in an interview.

The entanglements mean any company that wants Schering, which also has promising drugs in development for Alzheimer’s disease and asthma, has to strike a deal with J&J, she said.

“Basically these mega mergers are going to come back because the revenues in the pharma sector have no chance of growing and cost cutting can’t go much further for many companies,” said Navid Malik, an analyst at London-based Matrix Corporate Capital LLP, in an interview. “Any company that misses out on this round of mega mergers runs the risk of losing market share.”

Comments »

World Markets Fall As LLoyds of London Looses Control to the U.K. Government

Nationalization is here

March 9 (Bloomberg) — Stocks in Europe and Asia declined and U.S. index futures retreated after billionaire investor Warren Buffett said the economy has “fallen off a cliff” and the U.K. government took control of Lloyds Banking Group Plc.

Lloyds, Britain’s biggest mortgage lender, sank 9.3 percent, while the yield on the 10-year gilt fell to the lowest level since at least 1989. HSBC Holdings Plc plunged the most in at least 23 years in Hong Kong on concern that deepening loan losses at its U.S. unit will curb profits. Shinsei Bank Ltd., the Japanese lender partly owned by Christopher Flowers, slid 8.8 percent on plans to raise capital.

The MSCI World Index slipped 1.2 percent to 689.12 at 11:16 a.m. in London. A third government rescue for Citigroup Inc. and dividend cuts at companies from General Electric Co. to JPMorgan Chase & Co. have sent the gauge of 23 developed countries to a 25 percent drop this year, the worst start since the measure was created in 1970.

“Clearly we are in a deep recession and are still on the way down in most economies,” Michael Dicks, head of research and investment strategy at Barclays Wealth, which oversees about $203 billion, said on Bloomberg Television in London. “Nobody has sniffed the bottom to the point where they are willing to get their checkbook out” and buy equities, he said.

Futures on the Standard & Poor’s 500 Index fell 1.6 percent as Buffett said on CNBC that efforts to stimulate economic recovery may lead to inflation higher than the 1970s.

The global economy may shrink for the first time since World War II and trade will likely decline the most in 80 years, the World Bank said in a report yesterday. The assessment was more pessimistic than an International Monetary Fund report in January predicting 0.5 percent global growth this year.

Lonmin Declines

Europe’s Dow Jones Stoxx 600 Index slumped 2.1 percent to 156.11, extending a 12-year low as Lonmin Plc dropped. The regional gauge has declined 21 percent in 2009 as companies from Danisco A/S to Bayer AG gave disappointing forecasts and credit market related losses at financial firms worldwide climbed to almost $1.2 trillion.

The U.K.’s 10-year gilt yield dropped as much as 11 basis points to 2.95 percent, the lowest level since Bloomberg began tracking the data in 1989, while the pound slipped against the dollar and euro after the British government boosted its stake in Lloyds.

The MSCI Asia Pacific Index slid 1.7 percent. Japan’s Nikkei 225 Stock Average fell to the lowest level since October 1982 as the first current account deficit in 13 years fanned concern the economic slump is deepening. The yen slid against the dollar, euro and Swiss franc.

European Banks Drop

A gauge of banks posted the biggest drop among 19 groups in Europe’s Stoxx 600, retreating 5.3 percent. HSBC, the bank that’s raising 12.5 billion pounds ($17.5 billion) in a rights offer, lost 9.7 percent to 325.75 pence in London. The Hong Kong-listed shares plunged by a record 24 percent to HK$33, the lowest since May 1995.

HSBC Chairman Stephen Green last week said the 2003 purchase of Illinois-based Household International, which led to billions of dollars of losses as the U.S. housing market collapsed, was a mistake. CLSA Asia-Pacific Markets analyst Daniel Tabbush, who in December correctly predicted HSBC would have to raise money, cut his target price for the stock by 32 percent to HK$28, citing the threat of swelling bad debts.

Lloyds declined 9.3 percent to 38.1 pence. Britain’s biggest mortgage lender will cede control in exchange for tapping a guarantee program backing 260 billion pounds of assets. The government’s equity stake will rise to as much as 75 percent from 43 percent as a result of the transaction announced March 7.

‘Rotten Deal’

“It is a rotten deal,” said Roger Lawson, a spokesman for the U.K. Shareholders Association. “The original Lloyds shareholders are annoyed because their investment has effectively been destroyed.”

Barclays Plc slid 10 percent to 58.2 pence. The cost of protecting bonds sold by Barclays from default rose 15 basis points to 240, according to CMA Datavision prices for credit- default swaps.

Fortis limited the decline in the Stoxx 600’s bank index, rallying 27 percent to 1.22 euros. BNP Paribas SA, France’s biggest bank, agreed to acquire Fortis’s former banking units in Belgium and Luxembourg and take a stake in the insurance business after obtaining state guarantees on potential losses. BNP slipped 1.7 percent to 21.37 euros.

Shinsei, the worst-performing Japanese bank stock in the past 12 months, slumped 8.8 percent to 73 yen after saying it plans to sell preferred securities to rebuild a balance sheet ravaged by investment losses.

‘No New Money’

“Shinsei is managing to raise cash for now, which is good, but the fund-raising scheme gives rise to uncertainty,” said Shinichi Iimura, a senior banking analyst at Merrill Lynch & Co. in Tokyo. “There is no new money coming in.”

Lonmin slid 6.1 percent to 1,039 pence after JPMorgan cut its recommendation on the world’s third-biggest platinum producer to “underweight” from “neutral.”

“Lonmin has a great deal of work to do to restore its production costs to the levels seen four years ago,” analyst Steve Shepherd in Johannesburg wrote in a note. “This will require higher production volumes, which will take a couple of years to achieve.”

Schering-Plough Corp. jumped 21 percent to $21.44 in Germany, while Merck & Co. fell 4.3 percent to $21.76. Merck agreed to buy rival U.S. drugmaker Schering-Plough for $41.1 billion in cash and stock to get a larger experimental pipeline and products unhindered by imminent patent losses.

Graham, Buffett

The S&P 500, the benchmark index for U.S. equities, is still expensive by some measures even after the gauge dropped 56 percent in 17 months.

Benjamin Graham, the father of value investing and mentor of Buffett, measured equities against a decade of profits to smooth out distortions, a method that shows the S&P 500 trading at 13.2 times earnings, according to data compiled by Yale University Professor Robert Shiller. At the bottom of the three worst recessions since 1929, the average ratio fell below 10. To reach that level, the S&P 500 would sink another 27 percent.

Comments »

Weekend Edition

Shit The Bed

Is The Market Finished Shitting the Bed ?

Yes
No
Who knows
Who cares
I think 5k DOW is coming soon
I think 4k DOW is coming soon
I think 3k DOW is coming soon
  Current Results

To be lazy is good some times

[youtube:http://www.youtube.com/watch?v=v-OH285DdNM 450 300] [youtube:http://www.youtube.com/watch?v=nC1vn-IRFQ8 450 300] [youtube:http://www.youtube.com/watch?v=fOIM1_xOSro 450 300] [youtube:http://www.youtube.com/watch?v=x-AWGYifdUI 450 300]

Feel better funny man !

[youtube:http://www.youtube.com/watch?v=oEFR-eYaot0 450 300] [youtube:http://www.youtube.com/watch?v=xa40Va_JpWI 450 300] [youtube:http://www.youtube.com/watch?v=rfQGRvGAzKA 450 300] [youtube:http://www.youtube.com/watch?v=fx3nehSkVMQ&feature=related 450 300] [youtube:http://www.youtube.com/watch?v=LGO_3wuXFWw&feature=related 450 300]

Comments »

Nonfarm Payrolls: Prior 598k / Market Expects 650k / Actual 651k …. Unemployment Rate: Prior 7.6% / Market Expects 7.9% / Actual 8.1%… Futures Reduce Losses to Flatline… Plus Market Movers

Stocks on the move

More stocks on the move

Today’s Earnings

Commodities Board


Currencies Board


Metals Board


Energy Board

Comments »